Revenue ($USD) : $1,984,650,716 Revenue (foreign currencies) : JP¥260,900,000,000 R&D spend : $73,026,627.00 Employees : not available Fiscal year end : 03/31/23 CEO : Shigekazu Takeuchi
HU Group focuses on lab testing, related services and in vitro diagnostics. It also has a part of the business that provides support services related to hospital administration work. –CN